Dong Lü

Director/Board Member at Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd.

49 year

Consumer Services

Health Technology

Transportation

Profile

Dong Lü is currently a Director at Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd.
He was formerly a Director at InventisBio, Co., Ltd.
Dr. Lü holds a doctorate degree from China Pharmaceutical University.

Dong Lü active positions

Companies	Position	Start
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd. Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd. Air Freight/CouriersTransportation Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China.	Director/Board Member	2022-04-30

All active positions of Dong Lü

Former positions of Dong Lü

Companies	Position	End
INVENTISBIO CO., LIMITED	Director/Board Member	-

See the detail of Dong Lü's experience

Training of Dong Lü

China Pharmaceutical University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dong Lü's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
INVENTISBIO CO., LIMITED	Health Technology

Private companies	1
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd. Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd. Air Freight/CouriersTransportation Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China.	Transportation